Coronavirus News Highlights: Monoclonal antibody therapy 100% prevents severe disease and deaths, says study

By: |
Updated: November 2, 2021 11:11:23 pm

Coronavirus Vaccine Registration, Covid-19 India Latest Update, Coronavirus Cases in India Today's News, November 2 Highlights: India reports 10,423 new Covid-19 cases, lowest in 259 days

Coronavirus LIVE updates, Covid-19 third wave, festive guidelines, school reopeningThe total number of deaths due to Coronavirus complications crossed 5 million yesterday globally. (Picture: Reuters)

Coronavirus Variants and Vaccinations, Coronavirus Active Cases in India Today’s News, November 2 Highlights: It has been nearly two years since the Covid-19 pandemic hit the world. The fight against Coronavirus is not over yet. Even as people around the world prepare for normalcy, there are reports that suggest the virus is resurging in several regions. Countries such as the US, UK, Russia, China, Singapore, Ukraine, and other countries in Eastern Europe have witnessed a sharp spike in fresh coronavirus infections in the past few days. The UK witnessed a 14% rise in new cases at 283,756 cases (the highest), followed by Russia’s 217,322, according to data from the World Health Organization. The UK reported more than 50,000 cases for the first time since July 17; the Delta variant is the reason behind the surge, according to experts. However, infections due to AY.4.2 Delta sub-lineage are spreading rapidly, according to the latest reports. In less than two years, the total number of deaths due to Coronavirus complications crossed 5 million yesterday globally. The US alone has posted over 740,000 fatalities, more than any other nation. Together, the US, the EU, Britain, and Brazil – all upper-middle- or high-income countries – account for one-eighth of the world’s population but nearly half of all reported Covid deaths.

In India, though the Coronavirus situation is under control, there have been reports of a spike in new cases in some parts of the country after the Durga Puja festivals. West Bengal, Assam, and Himachal Pradesh witnessed up to 40% surge in fresh Coronavirus infection in the week after festivals. The emergence of the new Delta ‘sub variant’, AY.4.2 variant in Madhya Pradesh also raises the fear of a third wave.
Meanwhile, India has been reporting below 20,000 new Covid-19 cases for the past 25 days. Even though the uneven pace of vaccination remains a worry, the country has so far administered more than 106.85 crore Covid-19 vaccine doses. According to data from Union Health Ministry, nearly 35% eligible population is fully vaccinated.

Meanwhile, India reported 10,423 new Coronavirus cases, the lowest in 259 days, in the last 24 hours, taking its overall Covid-19 tally to 3,42,96,237, while the active cases declined to 1,53,776, the lowest in 250 days, according to data from the Union Health Ministry on Tuesday. With 443 fresh fatalities, The Covid-19 death toll surged to 4,58,880, according to the data updated at 8 am. The active cases now account for 0.45% of the total infections, the lowest since March 2020, while the national Covid-19 recovery rate improved to 98.21%, the highest since March 2020, the ministry said.

Here are the latest updates on Coronavirus from India and around the globe: 

Live Blog

Highlights

    23:08 (IST)02 Nov 2021
    Coronavirus Live Tracker: 11 fresh virus cases in Haryana, no death 

    Haryana on Tuesday reported 11 coronavirus cases, pushing the state's infection count to 7,71,273, according to a Health Department bulletin.

    No infection death was reported on Tuesday in the state, where so far 10,049 people have died from it.

    Eight cases were reported from Gurugram, two from Panchkula and one from Faridabad. The remaining 19 districts did not report any fresh case.

    The number of active cases in the state was 105 while the count of overall recoveries was 7,61,096.

    The recovery rate was 98.68 per cent, the bulletin said. (PTI)

    22:53 (IST)02 Nov 2021
    Coronavirus Live Tracker: 110 more coronavirus cases reported in Jammu and Kashmir 

    Jammu and Kashmir on Tuesday recorded 110 fresh cases of coronavirus, taking the infected number of people to 3,32,457 while two fresh deaths due to the virus were reported from the Union territory in the past 24 hours, officials said.

    Of the 110 fresh cases, 18 were from Jammu division and 92 from Kashmir division of the UT, the officials said.

    They said Srinagar district recorded the highest number of 42 cases followed by 21 cases each in Baramulla district.

    There are 916 active cases in the UT, while the number of recovered patients was 3,27,103, the officials said.

    The death toll in the UT due to the pandemic was 4,438 as two fresh deaths were reported in the past 24 hours.

    Meanwhile, the officials said there were 49 confirmed cases of mucormycosis (black fungus) in J-K as no fresh case was reported since Monday evening. (PTI) 

    22:48 (IST)02 Nov 2021
    Coronavirus Live Tracker: Assam reports 270 new COVID-19 cases, 7 more fatalities

    The COVID-19 death toll in Assam rose by seven for the second consecutive day on Tuesday, while the number of fresh infections marginally reduced to 270 taking the overall caseload to 6,11,211, a National Health Mission (NHM) bulletin said.

    The number of new cases declined by 26 from 296 on Monday.

    The day's positivity rate was 0.75 per cent, registering a slight increase from 0.70 per cent the previous day.

    The positivity rate had reached 1.41 per cent on Sunday.

    Among the fresh cases detected during the day, 126 were from Kamrup Metropolitan, 19 from Barpeta, and 16 each from Darrang and Kamrup (Rural).

    The new cases were detected out of 36,201 tests conducted during the day, taking the cumulative tests in the state so far to 2,47,90,707.

    COVID-19 fatalities were as high as seven for the second consecutive day after the number of deaths had been six or below for more than 10 days.

    Of the fresh fatalities, two each were reported from Kamrup Metropolitan and Lakhimpur, and one each from Barpeta, Jorhat and Kamrup (Rural).

    The coronavirus death toll in Assam has now reached 6,011.

    The number of COVID-19 patients dying due to other reasons remained at 1,347.

    As many as 159 were cured of the infection during the day, taking the number of recovered patients to 6,01,468, the bulletin said.

    The recovery rate among coronavirus patients is now 98.41 per cent.

    Currently, Assam has 2,385 active coronavirus cases.

    Meanwhile, over 2.85 crore beneficiaries have been inoculated with 83.40 lakh having received both doses of the vaccine, the bulletin said. (PTI)

    22:30 (IST)02 Nov 2021
    Coronavirus Live Tracker: At least 22 states, UTs reopened schools for all students, 92% teachers vaccinated, says Centre

    At least 22 states and Union Territories have reopened schools for all students after a prolonged closure due to the Covid pandemic while over 92 per cent of the teaching personnel in India have been vaccinated, the Union Education Ministry said on Tuesday.

    Union Education Minister Dharmendra Pradhan on Tuesday reviewed the reopening of schools and called for restoring normalcy in educational institutions in view of rapid inoculations in the country. | Read More

    22:17 (IST)02 Nov 2021
    Coronavirus Live Tracker: Nepal PM thanked PM Modi for providing vaccines to Nepal in a timely manner

    Nepal PM also thanked PM Modi for providing vaccines to Nepal in a timely manner, including 1 million doses  that have just been supplied. He also invited PM Modi to visit Nepal at the earliest as per his convenience: Foreign Secretary Harsh Vardhan Shringla in Glasgow (ANI) 

    21:58 (IST)02 Nov 2021
    Coronavirus Live Tracker: Madhya Pradesh reports 10 new COVID-19 cases, zero death; active tally at 121 

    The COVID-19 tally in Madhya Pradesh rose to 7,92,872 on Tuesday with the addition of ten fresh cases, while no new death due to the infection was reported in the state, a health department official said.

    The death toll remained unchanged at 10,524, the official added.

    The recovery count stands at 7,82,227, leaving the state with 121 active cases.

    With 52,180 samples examined during the day, the number of tests in MP went up to 2,03,95,656, the official added.

    An official release said 7,11,69,974 COVID-19 vaccine doses have been administered so far in the state, including 91,514 on Tuesday.

    Coronavirus figures in MP are as follows: Total cases 7,92,872, new cases 10, death toll 10,524 (no change), recovered 7,82,227, active cases 121, number of tests so far 2,03,95,656. (PTI) 

    21:45 (IST)02 Nov 2021
    Coronavirus Live Tracker: COVID-19 vaccination camp organised for transgenders in Jalna

    Maharashtra health minister Rajesh Tope on Tuesday inaugurated a COVID-19 vaccination camp for transgenders at the Government Women Hospital in Jalna. He said this was the second such camp being organised in the state, the first one being in Mumbai. He said transgenders should not be discriminated against and the state government was ensuring that its health services were all-inclusive. (PTI)

    21:34 (IST)02 Nov 2021
    Coronavirus Live Tracker: Sikkim logs 10 new COVID-19 cases, one more fatality

    Sikkim's COVID-19 tally rose to 31,994 as 10 more people tested positive for the virus while one new fatality pushed the coronavirus death toll to 397, a health department bulletin said on Tuesday. The Himalayan state had reported five COVID-19 cases on Monday and 22 on Sunday. Of the 10 new COVID-19 cases, East Sikkim district registered eight cases and West Sikkim two cases. Sikkim now has 170 active COVID-19, while 31,101 people have recovered from the disease. At least 326 COVID-19 patients have migrated to other states. The state's COVID-19 positivity rate and recovery rate are 2.4 per cent and 98.2 per cent respectively. A total of 2,61,901 samples have so far been tested for COVID-19, it added. (PTI) 

    21:23 (IST)02 Nov 2021
    Coronavirus Live Tracker: 50 per cent citizens yet to get vaccinated, says VP 

    Vice-President M Venkaiah Naidu on Tuesday expressed concern that about 50 per cent of citizens had not taken the coronavirus vaccine in the country and asked the politicians and media to educate people on this."Having a vaccine is duty of everybody. It's a protection. It is unfortunate that even now 50 per cent of people have not yet taken vaccine," the Vice-President said, addressing the 'Azadi Ka Amrit Mahotsav' at the Damodaram Sanjeevaiah National Law University here."What is this? What is happening? As if they are taking the vaccine for the sake of (Prime Minister) Modi or (Andhra Pradesh Chief Minister) Jagan Mohan Reddy. It is because of ignorance, being misled," Venkaiah Naidu observed.That 50 per cent of population did not get vaccinated was not due to lack of vaccine."It is available everywhere. Whoever asks, gets it free. So people should be educated. That's part of the duty of politicians and media to highlight," he said.Media should focus more on constructive attitude, should focus on unity and social responsibility, the Vice-President remarked. (PTI) 

    20:56 (IST)02 Nov 2021
    Coronavirus Live Tracker: Monoclonal antibody therapy 100 per cent prevents severe disease and deaths, says study 

    Monoclonal therapy reduces severe disease and death in high-risk individuals infected with the Delta variant of SARS CoV2 by 100 per cent, according to a new study.

    "In the world's first published study in a peer reviewed, high impact journal, AIG Hospitals along with the Asian Healthcare Foundation, CCMB Hyderabad and Institute of Life Sciences, successfully proved that the Monoclonal Therapy reduces severe disease and death in high-risk individuals infected with the Delta Variant of SARS CoV 2 by 100 per cent," the city-based AIG hospitals said in a release here on Tuesday.

    The key highlights from the study include -- More than 98 per cent samples tested were identified as the Delta Variant, 75 per cent patients who got the Monoclonal Therapy became RT-PCR Negative by seventh day and 78 per cent patients got relieved of their clinical symptoms like fever, cough, etc. by seventh day.

    The other highlights are that none of the study participants developed severe disease or died and there was no increase in inflammatory markers in these patients which causes severe disease, the release said.

    The highlights also include -- on follow up, none of the patients reported any post-COVID symptom and the neutralising activity of the Monoclonal Therapy was similar in both the original Wuhan Strain and the Delta Strain, it said.

    "The results are astonishing and will shape the public health policy for treatment of COVID-19 especially in high-risk individuals, those above age of 60 or even below 60 but with diabetes, hypertension, obesity, pregnant woman, people with chronic diseases, all will benefit immensely," said D Nageshwar Reddy, Chairman, AIG Hospitals.

    "We have clearly demonstrated in our research that when given at the right time, Monoclonal Therapy stops the progression of the disease completely," he said.

    The AIG Hospitals and its research arm, the Asian Healthcare Foundation conceptualized, designed, and funded the study. The patients were recruited from Fever Clinic at AIG Hospitals, the release said.

    The Centre for Cellular and Molecular Biology (a unit of CSIR) was involved in sequencing the genome of the virus strains collected to identify and confirm the Delta Variant and the Institute of Life Sciences, University of Hyderabad tested the neutralising activity of the cocktail against the delta variant in their lab, it said.

    The study was conducted on 285 high-risk individuals and published in the International Journal of Internal Medicine, the release said. (PTI) 

    20:40 (IST)02 Nov 2021
    Coronavirus Live Tracker: Pfizer tops Q3 forecasts as total COVID vaccine sales soar

    Pfizer beat third-quarter expectations and raised its 2021 forecast again even as sales of its top product, the COVID-19 vaccine Comirnaty, slipped in the U.S. Soaring international sales of the preventive shots helped pushed total Comirnaty revenue close to $13 billion in the quarter, and the drugmaker said Tuesday that it now expects to book about $36 billion in sales from the vaccine this year.

    That’s up from a second-quarter forecast for $33.5 billion and more than twice what Pfizer expected at the start of the year. Pfizer shares profits from the vaccine and costs to make and distribute it with German development partner BioNTech. In the U.S., third-quarter sales of the vaccine fell to $1.59 billion from a little over $2 billion the previous quarter. | Read More

    20:26 (IST)02 Nov 2021
    Coronavirus Live Tracker: Nagaland reports 9 fresh COVID-19 cases, one new death

    Nagaland reported nine new COVID-19 cases on Tuesday, eight less than the previous day, pushing the coronavirus tally to 31,868, a health department official said.Of the nine new cases, four were reported in Kohima district, three from Dimapur and two from Wokha district.The COVID-19 death toll rose to 686 as one more person succumbed to the disease, he said.Eighteen COVID-19 patients recovered from the disease on Tuesday, taking the total number of recoveries to 29,932.The COVID-19 recovery rate now is 93.92 per cent, he said.Nagaland currently has 205 active COVID-19 cases while 1,045 coronavirus patients have migrated to other states.As many as 3,96,580 samples have been tested for COVID-19 in the state so far.State Immunisation Officer Dr Ritu Thurr said a total of 12,07,130 doses of COVID-19 vaccines have been administered to 7,11,773 people till Monday. (PTI) 

    20:06 (IST)02 Nov 2021
    Coronavirus Live Tracker: Kerala logs 6,444 new cases, 187 deaths 

    Kerala recorded 6,444 fresh COVID-19 cases and 187 related deaths which raised the caseload to 49,80,398 and the fatalities to 32,236, the state government said on Tuesday.With 8,424 more people recovering from the virus since Monday, the total recoveries touched 48,72,930 and the active cases reached 74,618, an official press release said.Of the 187 deaths, 45 were reported over the last few days, 87 were those which were not confirmed until June 18 last year due to lack of adequate documentation and 55 were designated as COVID deaths after receiving appeals based on the new guidelines of the Centre and Supreme Court directions, the release said.As many as 64,999 samples were tested in the last 24 hours.Among the 14 districts, Thiruvananthapuram recorded the highest with 990 cases followed by Ernakulam (916) and Thrissur (780).Of the new cases, 31 were health workers, 48 from outside the state and 5,913 infected through contact with the source of it not being clear in 452.There are currently 2,62,454 people under surveillance in various districts, of whom 2,55,881 are in home or institutional quarantine and 4,886 in hospitals. (PTI) 

    19:47 (IST)02 Nov 2021
    Coronavirus Live Tracker: Hard-hit Russia sets another daily record for COVID deaths

    Coronavirus deaths in Russia hit another daily record on Tuesday, four days since a nationwide order for many Russians to stay off work took effect.

    Russia's state coronavirus task force reported 39,008 new confirmed cases and 1,178 COVID-19 deaths. The task force has reported record daily infections or deaths almost every day for the last month.

    To reduce the spread of the coronavirus, Russian President Vladimir Putin ordered a nationwide non-working period for October 30-November 7.

    Putin has said that governments in regions where the situation is most dire could add more non-working days, if needed.

    The Novgorod region became the first one to do so Monday, extending the period by another week.

    Putin spokesman Dmitry Peskov on Tuesday brushed off rumors that the non-working period could be prolonged for all of Russia.

    He stressed that regional governments have been empowered to introduce their own measures to curb the outbreak.

    Russia's weekslong surge in infections and deaths comes amid low vaccination rates, lax public attitudes toward taking precautions and the government's reluctance to toughen restrictions.

    Less than 35 per cent of Russia's nearly 146 million people have been fully vaccinated so far, even though Russia approved a domestically developed vaccine against the coronavirus months before most countries.

    Putin on Monday described the situation with COVID-19 in Russia as “very difficult.” In all, Russia's state coronavirus task force has reported nearly 8.6 million confirmed coronavirus cases and over 240,000 deaths in the pandemic — by far the highest death toll in Europe.

    However, reports by Russia's state statistical service Rosstat that tally coronavirus-linked deaths retroactively reveal much higher mortality numbers. A report released last week indicated that some 462,000 people with COVID-19 died between April 2020 and September of this year.

    Russian officials have said the task force only includes deaths for which COVID-19 was the main cause and uses data collected from medical facilities. Rosstat uses wider criteria for counting virus-related deaths and takes its numbers from civil registry offices where the process of registering a death is finalized. (AP)

    19:21 (IST)02 Nov 2021
    Coronavirus Live Tracker: Delhi reports 34 new COVID-19 cases, zero deaths in last 24 hours 

    Delhi reports 34 new COVID-19 cases, 42 recoveries, and zero deaths in the last 24 hours 

    Active cases: 309Total recoveries: 14,14,522Death toll: 25,091 (ANI) 

    19:04 (IST)02 Nov 2021
    Coronavirus Live Tracker: PM will interact with District Magistrates of over 40 districts 

    PM will interact with District Magistrates of over 40 districts in Jharkhand, Manipur, Nagaland, Arunachal Pradesh, Maharashtra, Meghalaya, & other States with districts having low vaccination coverage. CMs of these States will also be present in the meeting tomorrow: PMO (ANI)

    18:45 (IST)02 Nov 2021
    Coronavirus Live Tracker: PM to virtually hold a review meeting with districts having low COVID-19 vaccination coverage on Wednesday noon

    Prime Minister Narendra Modi will virtually hold a review meeting with districts having low COVID-19 vaccination coverage on Wednesday at 12 noon. (ANI)

    18:30 (IST)02 Nov 2021
    Coronavirus Live Tracker: Kerala reports 6,444 fresh COVID cases, 45 deaths today

    Kerala reports 6,444 fresh COVID cases, 8424 recoveries, and 45 deaths today

    Active cases: 74,618Total recoveries: 48,72,930Death toll: 32, 236 (ANI) 

    18:30 (IST)02 Nov 2021
    Coronavirus Live Tracker: Kerala reports 6,444 fresh COVID cases, 45 deaths today

    Kerala reports 6,444 fresh COVID cases, 8424 recoveries, and 45 deaths today

    Active cases: 74,618Total recoveries: 48,72,930Death toll: 32, 236 (ANI) 

    18:30 (IST)02 Nov 2021
    Coronavirus Live Tracker: Kerala reports 6,444 fresh COVID cases, 45 deaths today

    Kerala reports 6,444 fresh COVID cases, 8424 recoveries, and 45 deaths today

    Active cases: 74,618Total recoveries: 48,72,930Death toll: 32, 236 (ANI) 

    18:14 (IST)02 Nov 2021
    Coronavirus Live Tracker: Odisha launches campaign to boost COVID-19 vaccination

    With a large portion of the population yet to get inoculated in Odisha, the state government Tuesday launched a campaign to motivate people to come forward for full COVID-19 vaccination of two doses, a health department official said.The drive - ‘Har Ghar Dastak'- aims at tracing non-vaccinated people with the help of ASHA and Anganwadi workers, who will conduct door-to-door visits in villages and prepare a list.The campaign will continue for a month, said Director of Family Welfare Bijay Panigrahi, who is also the state's nodal officer for immunisation.”Over 30 lakh people have not taken the second dose of Covid vaccine in Odisha. The first dose target will be complete by December. More vaccination centres will be set up in villages,” he said.So far, 3,74,63,734 vaccine doses have been administered in the state, officials said.Meanwhile, Odisha on Tuesday registered 327 fresh infections, including 44 children and adolescents in the age group of 0-18 years, pushing the caseload to 10,42,100.It had reported 316 new cases on Monday.Khurda district, comprising state capital Bhubaneswar, logged the highest number of 177 cases, followed by Cuttack (29).Twelve of the 30 districts did not report any new COVID-19 case in the last 24 hours, the health department official said.The state's coronavirus death toll mounted to 8,340 after four more patients, one each from Balasore, Jagatsinghour, Khurda and Puri, succumbed to the virus.Odisha now has 4,122 active cases, while 10,29,585 patients, including 438 since Monday, have recovered from the highly infectious disease.The positivity rate stands at 4.71 per cent, he added. (PTI)

    17:56 (IST)02 Nov 2021
    Coronavirus Live Tracker: Active Covid-19 cases fall to 4,000 in Andhra Pradesh 

    Active Covid-19 cases in Andhra Pradesh dropped to the 4,000-mark even as the state added 259 fresh positives in 24 hours ending 9 AM on Tuesday.The latest bulletin said 354 infected persons recovered and five more succumbed in the state in 24 hours.The gross positives now climbed to 20,66,929, recoveries to 20,48,505 and deaths 14,382.The active caseload is 4,042.Chittoor district added 48, Guntur 41, East Godavari 34, Krishna 29, Visakhapatnam 23, Srikakulam 22 and West Godavari 21 fresh cases. Of the remaining six districts, SPS Nellore added 15 and the remaining less than 10 each in a day.Guntur reported two, Krishna, Prakasam and West Godavari one fresh fatality each in a day. (PTI) 

    17:30 (IST)02 Nov 2021
    Coronavirus Live Tracker: Compound that can potentially ease COVID-19 symptoms identified 

    Scientists have identified a compound that shows potential in easing the symptoms of COVID-19 infection in laboratory and animals.

    The team, from the US Department of Energy's Pacific Northwest National Laboratory (PNNL) and the University of North Carolina (UNC) studied the virus that causes Middle East Respiratory Syndrome, which is caused by a coronavirus.

    MERS is much less common, but much more lethal, than COVID-19.

    The study, published in the journal mBio, analysed tens of thousands of measurements in laboratory of proteins, molecular messengers and other signals that occur after infection.

    The researchers pinpointed a molecular process, part of the body's quality-control machinery, that plays a central role in causing damage from a coronavirus infection.

    They then searched a vast database of compounds and identified one known as AMG PERK 44 that put a halt to virus reproduction in human tissue in the laboratory.

    The team also found the compound has a strong effect in mice infected with the virus. The compound boosted lung function and reduced lung damage and weight loss in the mice, particularly in male mice, according to the researchers.

    "Studies like this help us learn more about how deadly respiratory viruses operate, how they do what they do, why they attack certain parts of the lung and not others," said virologist Amy Sims, one of two first coauthors of the paper from PNNL, along with Hugh Mitchell.

    The scientists noted that it is far too soon to know whether the compound could help patients as it is not currently used as a drug. The results of the study are most useful as part of a broader effort to learn more about respiratory diseases, they added.

    "Coronavirus infections cause complex disease phenotypes, and new strategies are needed to disentangle which host pathways are contributing to the development of severe, life-threatening outcomes," Ralph Baric from UNC added.  (PTI) 

    17:16 (IST)02 Nov 2021
    Coronavirus Live Tracker: Delhi logs 34 COVID-19 cases, zero death in a day 

    The national capital reported 34 cases of COVID-19 and zero death in a day while the positivity rate stood at 0.07 per cent, according to data shared by the health department here on Tuesday.

    Delhi recorded only four deaths due to the viral infection in October, while five people succumbed to the viral disease in September.

    With the new cases, the coronavirus infection tally in the city climbed to 14,39,922. Of this, over 14.14 lakh patients have recovered from the disease. The death toll stands at 25,091.

    According to the health bulletin, authorities conducted 48,831 tests, including 36,940 RT-PCR ones, the previous day. There are 309 active Covid cases in Delhi, of which 141 are in home-isolation. The number of containment zones stands at 98.

    Delhi reported 18 cases of COVID-19 on Monday, 45 on Sunday and 37 cases on Saturday.

    In April and May, the city battled a brutal second wave of the pandemic that claimed a massive number of lives and led to a shortage of oxygen and essential drugs at hospitals.

    On April 20, Delhi had reported 28,395 cases, the highest in the city since the beginning of the pandemic. On April 22 the case positivity rate was 36.2 per cent, the highest so far. The highest number of 448 deaths was reported on May 3.

    According to the sixth serosurvey, 97 per cent of the population in Delhi have developed antibodies against coronavirus as a result of a large number of people getting exposed to the virus during the second wave and robust vaccination.

    All districts in the capital have a seroprevalence of more than 93 per cent. Four districts -- south, central, northeast and east -- have recorded seropositivity of 99 per cent, 99.5 per cent, 99.7 per cent and 99.8 per cent, respectively.

    Women (90.1 per cent) have a higher seropositivity rate than men (88.2 per cent). Those aged below 18 have a seropositivity rate of 88 per cent.

    Ninety-five per cent of the vaccinated people who have a history of COVID-19 infection have developed antibodies as compared to 82 per cent of unvaccinated ones.

    According to government data, over 2.05 crore vaccine doses have been administered in Delhi since the inoculation exercise started on January 16. Over 74 lakh people have received both doses. (PTI) 

    15:58 (IST)02 Nov 2021
    Coronavirus Live Tracker: Nine new Covid cases in Ladakh

    Ladakh recorded nine fresh COVID-19 cases that raised the tally to 20,971, while the number of active cases in the Union Territory has reached 76, officials said on Tuesday. Ladakh has registered 207 coronavirus-related deaths -- 149 in Leh and 58 in Kargil -- since the outbreak of the pandemic last year. No new fatality due to COVID-19 has been reported in Ladakh. The recovery count remained unchanged at 20,687 as no new coronavirus patient was discharged from hospitals, they said. All the fresh cases were reported from Leh, they said. A total of 209 sample reports in Ladakh tested negative for the virus, they said. (PTI)

    15:27 (IST)02 Nov 2021
    Coronavirus Live Tracker: Romania's COVID-19 deaths at new record high

    Romania reported record numbers of daily coronavirus deaths on Tuesday, data showed, and there were no available intensive care beds across the European Union's second-least vaccinated state. New infections in the preceding 24 hours topped 11,000 but down from a peak seen in October, while 591 people died of the virus, preliminary official data showed. The pandemic has killed 48,664 people in the country so far. Romania has fully vaccinated roughly 37% of its adult population and although daily inoculation numbers have risen in recent weeks, scepticism remains elevated because of distrust in state institutions and misinformation campaigns. (Reuters)

    15:01 (IST)02 Nov 2021
    Coronavirus Live Tracker: Private S.Korea firms plan $5.4 bln investment to create vaccine hub

    South Korea's private sector plans to invest 6.3 trillion won ($5.4 billion) in vaccine production and distribution by 2024, as the country seeks to become a global vaccine powerhouse, Prime Minister Kim Boo-kyum said on Tuesday.South Korea already has deals to produce three coronavirus vaccines developed by AstraZeneca/Oxford University, Novavax, and Russia. It also has a vaccine bottling and packaging agreement with Moderna.The investment plan includes 4.24 trillion won spending by Samsung BioLogics and 1.5 trillion won by drugmaker Celltrion, the government data showed.Kim said the government had selected 14 companies in the vaccine supply chain eligible for 18 billion won of state financial support, as the government develops the industry to become a major pillar.The selected companies include Hanmi Pharmaceuticals , ST Pharm and Cellid. - Reuters

    14:17 (IST)02 Nov 2021
    Coronavirus Live Tracker: Russia's daily COVID-19 death toll rises to new record high

    Russia's daily COVID-19 death toll rose to a record high of 1,178 on Tuesday amid a surge that has forced officials to re-impose a partial lockdown nationwide. The government coronavirus task force also reported 39,008 new infections in the last 24 hours, including 5,736 in Moscow. (Reuters)

    14:11 (IST)02 Nov 2021
    Coronavirus Live Tracker: Bahrain approves Pfizer COVID vaccine for children aged 5-11

    Gulf state Bahrain has approved the Pfizer COVID-19 vaccine for emergency use for children aged between 5 and 11 years, the government media office said on Tuesday. The decision came after a study involving 3,100 children aged between 5 and 11 who were administered with the vaccine found it to be 90.7% effective in that age group, said the statement, citing the National Health Regulatory Authority. None of the children involved in the study showed severe side effects, it said. Bahrain will be supplied with doses from the manufacturer for the 5-11 age group from the start of 2022, it said. (Reuters) 

    13:54 (IST)02 Nov 2021
    Coronavirus Live Tracker: 18 children orphaned due to COVID-19 in Raigad get Rs 5 lakh in FD

    At least 18 children, who lost a parent to COVID-19, received certificates of fixed deposits of Rs 5 lakh each in Maharashtra's Raigad district, an official said on Tuesday. District Guardian Minister Aditi Tatkare distributed the certificates to relatives of such children at a function held in Pali on Monday, the official said. The affected children will get 1 per cent reservation in government jobs when they reach adulthood, while relatives will get Rs 1,100 per month as financial assistance from the state government for the care, he added. (PTI)

    13:32 (IST)02 Nov 2021
    Coronavirus Live Tracker: China won't give up on its zero-tolerance COVID policy soon - experts

    China will not give up on its zero-tolerance policy towards local COVID-19 cases any time soon, some experts said, as the policy has allowed it to quickly quell local outbreaks, while the virus continues to spread outside its borders. To stop local cases from turning into wider outbreaks, China has developed and continually refined its COVID-fighting arsenal -- including mass testing, targeted lockdowns and travel restrictions - even when those anti-COVID measures occasionally disrupted local economies. "The policy (in China) will remain for a long time," Zhong Nanshan, a respiratory disease expert who helped formulate China's COVID strategy in early 2020, told state media. "How long it will last depends on the virus-control situation worldwide."In a major outbreak in July-August, China counted a total ofover 1,200 local symptomatic infections. In the latest flare-up, mostly in northern China, some 538 local cases were reported between Oct. 17 and Nov. 1. Despite the lower caseload, the geographical spread of the infections has put constraints on China's leisure and tourism sectors. Since Oct. 23, travel agencies have not been allowed to organise tourism between certain provinces, with such restrictions affecting trips to nearly one-third of the mainland's 31 province-level regions including Beijing. Many cities with infections have also closed indoor entertainment and cultural venues. A flurry of marathons, theatrical performances and concerts have been delayed or cancelled. China also requires weeks of quarantine for most travellers arriving from abroad. In contrast, some Asia-Pacific countries are starting to open selectively to fully vaccinated international travellers as they seek to secure a more normal footing for their economies and societies. (Reuters)

    13:21 (IST)02 Nov 2021
    Coronavirus Live Tracker: Six new cases take Arunachal's COVID tally to 55,161

    Arunachal Pradesh on Tuesday reported six fresh COVID-19 cases, five more than the previous day, with the tally increasing to 55,161, a health department official said. Twenty-two people recuperated from the disease in the last 24 hours, taking the total number of recoveries to 54,796, State Surveillance Officer (SSO) Dr Lobsang Jampa said. The recovery rate among coronavirus patients in the state currently stands at 99.34 per cent.  The death toll remained at 280 as no new fatality due to the infection was reported since Monday, the SSO said. Arunachal Pradesh now has 85 active cases. Lower Dibang Valley district has the highest number of active cases at 16, followed by Tawang (15), West Kameng (13) and East Siang (10). (PTI)

    13:14 (IST)02 Nov 2021
    Coronavirus Live Tracker: Centre's vaccination scheme has created 2 classes of citizens in India, says Kerala HC

    The Centre's vaccination scheme has created two classes of citizens in India - those who got COVAXIN, whose movements are restricted, and those who received COVISHIELD and can go anywhere -- Kerala High Court said on Tuesday. The observation by Justice P V Kunhikrishnan came during the hearing of a man's plea for a third jab of an internationally recognised vaccine so that he can go abroad for work. The man, who was working as a welder in Saudi Arabia, moved the court for a third jab as the two doses of COVAXIN he has received is not recognised or approved in the Gulf nation and therefore, he stands to lose his job there as he cannot go there without being vaccinated by an internationally recognised vaccine. "Due to the State-sponsored vaccination scheme, there are two types of citizens in the country - those who received COVAXIN and those who got COVISHIELD. The former's movement is restricted, while the latter can go anywhere," the court said. It said the creation of two classes of citizens has resulted in "infringement of the fundamental right of movement of the petitioner". "His movement is restricted. A citizen is suffering due to a State-sponsored vaccination scheme. It is a clear case of infringement of the fundamental rights of the petitioner," the court observed. (PTI)

    13:14 (IST)02 Nov 2021
    Coronavirus Live Tracker: Centre's vaccination scheme has created 2 classes of citizens in India, says Kerala HC

    The Centre's vaccination scheme has created two classes of citizens in India - those who got COVAXIN, whose movements are restricted, and those who received COVISHIELD and can go anywhere -- Kerala High Court said on Tuesday. The observation by Justice P V Kunhikrishnan came during the hearing of a man's plea for a third jab of an internationally recognised vaccine so that he can go abroad for work. The man, who was working as a welder in Saudi Arabia, moved the court for a third jab as the two doses of COVAXIN he has received is not recognised or approved in the Gulf nation and therefore, he stands to lose his job there as he cannot go there without being vaccinated by an internationally recognised vaccine. "Due to the State-sponsored vaccination scheme, there are two types of citizens in the country - those who received COVAXIN and those who got COVISHIELD. The former's movement is restricted, while the latter can go anywhere," the court said. It said the creation of two classes of citizens has resulted in "infringement of the fundamental right of movement of the petitioner". "His movement is restricted. A citizen is suffering due to a State-sponsored vaccination scheme. It is a clear case of infringement of the fundamental rights of the petitioner," the court observed. (PTI)

    13:09 (IST)02 Nov 2021
    Coronavirus Live Tracker: Delhi police issued over 3 lakh challans for violating Covid norms since Apr

    Delhi Police issued over three lakh challans between April 19 and November 1 this year for violation of various COVID-19 norms, maximum for not wearing face mask, officials said on Tuesday. Of the total 3,14,556 challans, 2,78,121 were issued for not wearing mask, followed by 30,364 to those not adhering to social distancing norms, and 2,923 for consumption of liquor, pan, gutkha, tobacco etc, according to the latest data shared by Delhi Police. Another 1,684 challans were issued for spitting and 1,464 for holding large public gatherings and congregation. On Monday, police issued a total of 279 challans. Out of them, 266 were issued for not wearing mask and 13 for consumption of liquor, pan, gutkha, tobacco etc., police said. The unlock process began in Delhi in a phased manner with the government allowing construction and manufacturing activities from May 31. (PTI)

    13:08 (IST)02 Nov 2021
    Coronavirus Live Tracker: Covid vaccinated people with prior infection may have more antibodies, says study

    Antibody levels against SARS-CoV-2, the virus that causes COVID-19, stay more durable in people who were infected by the disease and then received two doses of vaccine compared with those who only got immunised, according to a study. The research, published in Journal of the American Medical Association on Monday, followed 1,960 health care workers in the US who had received both doses of either the Pfizer/BioNTech or Moderna vaccines. This included 73 people who had a positive SARS-CoV-2 polymerase chain reaction (PCR) test result before the first vaccine dose. The 73 were divided into two groups -- those who were infected at 90 days or closer to the first vaccine dose, and those whose exposure to the virus was more than 90 days before the initial shot. After adjusting for vaccine type, age and sex, antibody levels were compared for those with and without prior SARS-CoV-2 infection at one, three and six months following the second vaccine dose. The antibody levels were also compared at one and three months following the second dose between the two groups with prior SARS-CoV-2 infection. The two mRNA vaccines evaluated in the study introduce the body's immune system to S1, a protein subunit that is a component of the spikes found on the surface of SARS-CoV-2. (PTI)

    12:55 (IST)02 Nov 2021
    Coronavirus Live Tracker: Umpire Gough put in isolation for COVID-19 breach at World Cup

    English umpire Michael Gough has been put in isolation for six days for breaching COVID-19 health protocols during the Twenty20 World Cup, the International Cricket Council said on Tuesday. The 41-year-old former first-class cricketer was withdrawn from New Zealand's Super 12 clash against India on Sunday in Dubai and replaced by Marais Erasmus of South Africa." The Bio-Security Advisory Committee has instructed umpire Michael Gough to isolate for six days due to a breach of the event bio-security protocols," an ICC spokesperson said in a statement. Reports in British media said he had breached his hotel 'bubble'. Players and match officials are staying in designated hotels where their movements are monitored and they are not allowed to mingle with those outside the bubble as part of the protocols. The world governing body did not clarify if Gough would face any further sanction for the breach. (Reuters)

    12:54 (IST)02 Nov 2021
    Coronavirus Live Tracker: Czech daily COVID-19 cases top 7,500, highest since March

    The Czech Republic recorded 7,591 new COVID-19 cases on Nov. 1, the highest daily tally since the end of March, Czech Radio reported on Tuesday. On the same day last week, 4,277 cases were detected. The country of 10.7 million has 1,813 people hospitalised with the illness, 284 of whom are in intensive care. As of Monday, 6.09 million people were fully vaccinated.(Reuters)

    12:53 (IST)02 Nov 2021
    Coronavirus Live Tracker: China administered 2.279 bln doses of COVID-19 vaccines as of Nov 1

    China administered about 5.4 million doses of COVID-19 vaccines on Nov. 1, bringing the total number of doses administered to 2.279 billion, data from the National Health Commission showed on Tuesday. (Reuters)

    12:15 (IST)02 Nov 2021
    Coronavirus Live Tracker: White House says 15 mn COVID-19 shots will roll out to children by next week

    The United States is rolling out Pfizer/BioNTech COVID-19 vaccines for children aged 5 to 11 this week, but most of the 15 million shots being shipped initially are unlikely to be available before next week, theWhite House said on Monday. Millions of doses specifically formulated for children of that age group will start arriving at distribution centers over the next few days, White House coronavirus response coordinator Jeff Zients said, and the federal government has purchased enough supply for all eligible 28 million children. "We are ready to execute, pending CDC's decision. And starting the week of November 8th, our vaccination program for kids ages 5 through 11 will be running at full strength," Zients told reporters at a briefing. (Reuters)

    Next Stories
    1EXCLUSIVE: Optum India MD Ritesh Talpatra on making healthcare affordable and leveraging technology
    2Serum Institute seeks DCGI’s approval for Covishield as booster dose
    3Mandaviya tables Assisted Reproductive Technology Bill for regulation of clinics